posted 01-10-2008 06:17 PM            

Leveraging proprietary dye technologies, AnaSpec has developed a broad portfolio of products based on fluorescence energy transfer (FRET) technology, most notably the SensoLyte™ line of high-performance assay kits. Showcasing this technology, AnaSpec has announced the availability of its new FRET Technology Brochure.

The detection of proteases and screening of specific protease inhibitors are critical factors in the discovery of potential drugs for the treatment and management of protease-related diseases. In the last decade or so, the use of fluorescence resonance energy transfer (FRET) technology has made the continuous assay of protease activity and high throughput screening (HTS) of protease inhibitors faster and easier.

AnaSpec’s SensoLyte™ line offers the industry’s first and most sensitive collection of long wavelength protease assay kits. Combining proprietary FRET technologies with world-class peptide expertise, the SensoLyte™ family demonstrates significantly superior performance over traditional assay kits. The perfect overlap of absorption and emission spectrums of the SensoLyte™ FRET pairs allows for a level of sensitivity that is as much as 40x greater.

AnaSpec’s newly-released FRET Technology Brochure features:

• SensoLyte™ protease assay kits for HTS of inhibitors or quantitation of HCV, HIV, MMPs,  and -Secretases, Renin, TACE, ACE2, & WNV.
• Table of the different donor and acceptor molecules
• Listing of dye-labeled amino acids or resins that can be used as building blocks
• Concise guideline on how to design FRET peptides

Company Info

AnaSpec, Inc. is a leading provider of integrated proteomics solutions to pharmaceutical, biotech, and academic research institutions throughout the world. With a vision for innovation through synergy, AnaSpec focuses on three core technologies: peptides, detection reagents (dyes, assay kits, & antibodies), and combinatorial chemistry.
For more information, visit www.anaspec.com